Profile
BDXB ISRG BDX BDXA ALC RMD
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $13.69B $191.29B $49.98B $48.71B $43.43B $37.41B
Employees 77.00K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Thomas E. Polen Jr. Gary S. Guthart Mr. Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
BDXB ISRG BDX BDXA ALC RMD
Quant Rating Score 4 3 3 5 3 3
Quant Rating Buy Neutral Neutral Strong Buy Neutral Neutral
Trading
BDXB ISRG BDX BDXA ALC RMD
Last Close $48.16 $543.41 $172.25 $59.24 $88.28 $258
High 52 $48.16 $610.45 $249.08 $59.24 $100.76 $258
Low 52 $48.16 $416.14 $165.15 $59.24 $82.73 $186.94
Price vs. 52 Week High 0 % -10.98 % -30.85 % 0 % -12.39 % 0 %
Price vs. 52 Week Low 0 % 30.58 % 4.3 % 0 % 6.71 % 38.01 %
Total Return
BDXB ISRG BDX BDXA ALC RMD
1 Month Return 0 % -1.62 % -0.2 % 0 % 2.72 % 5.4 %
3 Month Return 0 % 9.48 % -23.8 % 0 % -4.77 % 16.06 %
6 Month Return 0 % 4.11 % -24.08 % 0 % 3.99 % 12.82 %
9 Month Return 0 % 12.1 % -28.73 % 0 % -10.94 % 8.06 %
YTD Return 0 % 4.11 % -24.08 % 0 % 3.99 % 12.82 %
1 Year Return 0 % 24.57 % -24.87 % 0 % 0.24 % 38.01 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDXB ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) 2.38 % - 2.33 % 2.38 % 0.38 % 0.83 %
Dividend Paid and Capex Coverage Ration (TTM) 1.77 % 2.77 % 1.77 % 1.77 % 4.15 % 4.21 %
Dividend Per Share (TTM) 4.07 % - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) 76.77 % - 76.77 % 76.77 % 11.23 % 23.14 %
Profitability
BDXB ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 44.5 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM 2.75 % 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM 5.86 % 15.52 % 5.86 % 5.86 % 6.95 % 25.18 %
Return on Capital Employed TTM 5.05 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 89.01 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 71.19 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM 11.33 % 28.2 % 11.33 % 11.33 % 15.22 % 32.1 %
Cash Flow To Debt Ratio TTM 17.12 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM 6.89 6.46 6.89 6.89 5.35 5.53
Payables Turnover TTM - 10.39 - - 5.25 9.36
Inventory Turnover TTM 3.11 1.85 3.11 3.11 1.89 2.41
Fixed Asset Turnover TTM 313.98 % 181.6 % 313.98 % 313.98 % 202.74 % 729.93 %
Asset Turnover TTM 38.31 % 45.34 % 38.31 % 38.31 % 32.06 % 66.36 %
Operating Cash Flow Per Share TTM 11.44 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM 8.98 4.88 8.98 8.98 3.47 10.66
Cash Per Share TTM 236.81 % 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM 15.81 % 31.34 % 15.81 % 15.81 % 21.14 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.51 % 63.9 % 78.51 % 78.51 % 81.86 % 94.64 %
Cash Flow Coverage Ratios TTM 17.12 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM 18.91 109.6 19.3 18.91 25.25 23.92
Price To Operating Cash Flows Ratio TTM 14.94 69.86 15.25 14.94 20.69 22.65
Price Cash Flow Ratio TTM 14.94 69.86 15.25 14.94 20.69 22.65
Income Statement (TTM)
BDXB ISRG BDX BDXA ALC RMD
Revenue $20.18B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $9.13B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio 45.22% 67.46% 45.22% 45.22% 55.61% 56.67%
EBITDA $4.82B $2.81B $4.82B $4.82B $2.68B $1.53B
Net Income $1.71B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted 5.86 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
BDXB ISRG BDX BDXA ALC RMD
Long Term Debt $17.94B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $31.4B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $25.89B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0.45B $6.89B $0.45B $0.45B $0.75B $0.17B
Total Debt $20.11B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $57.29B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
BDXB ISRG BDX BDXA ALC RMD
Net Income $1.71B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $0.1B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $-1.1B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $3.8B $2.42B $3.8B $3.8B $2.08B $1.4B
Capital Expenditure $-0.73B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.34
ALC Alcon Inc. 89
ANGO AngioDynamics, Inc. 9.51
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 159.1
ATRC AtriCure, Inc. 32.21
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 31.78
BAX Baxter International Inc. 31.22
BDX Becton, Dickinson and Company 177.66
BDXA Becton, Dickinson and Company 59.24
BLCO Bausch + Lomb Corporation 13.45
BLFS BioLife Solutions, Inc. 21.65
COO The Cooper Companies, Inc. 72.82
DXR Daxor Corporation 9.65
EKSO Ekso Bionics Holdings, Inc. 3.34
FEMY Femasys Inc. 0.945
GCTK GlucoTrack, Inc. 6.39
ETFs With Exposure to BDXB
Ticker ETF Name Weight Percentage Price
FCVT First Trust SSI Strategic Convertible Securities ETF 0.39 38.47
HSUN Hartford Sustainable Income ETF 0.134074 33.534
QPFF American Century Quality Preferred ETF 0.68 35.27
Unlock